title: Antiproliferative effects of rapamycin and celecoxib in angiosarcoma cell lines.
authors.affiliation: Department of Dermatology, University of Regensburg, Regensburg, Germany.
authors.forename: Annika
authors.initials: A
authors.lastname: Bundscherer
authors.forename: Thomas
authors.initials: T
authors.lastname: Vogt
authors.forename: Gudrun
authors.initials: G
authors.lastname: Köhl
authors.forename: Michael
authors.initials: M
authors.lastname: Landthaler
authors.forename: Christian
authors.initials: C
authors.lastname: Hafner
mesh_terms: D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000494:pharmacology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology*; D000068579:Celecoxib; D048708:Cell Growth Processes / Q000187:drug effects; D045744:Cell Line, Tumor; D052246:Cyclooxygenase 2 Inhibitors / Q000008:administration & dosage / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D006394:Hemangiosarcoma / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D051379:Mice; D011720:Pyrazoles / Q000008:administration & dosage / Q000494:pharmacology*; D020123:Sirolimus / Q000008:administration & dosage / Q000494:pharmacology*; D013449:Sulfonamides / Q000008:administration & dosage / Q000494:pharmacology*
chemical_list: D000903:Antibiotics, Antineoplastic; D052246:Cyclooxygenase 2 Inhibitors; D011720:Pyrazoles; D013449:Sulfonamides; D000068579:Celecoxib; D020123:Sirolimus